You Searched For "zydus cadila company" and got 20 results
Sort By:
These are the companies that are making Remdesivir in India
Dr Reddy’s Lab is the sixth pharmaceutical company to introduce Remdesiv…
After Dr Reddy’s Lab, Zydus Cadila is reportedly in talks with Russia for its COVID-19 vaccine despite concerns over its safety
Zydus Cadila is already working on its own COVID-19 vaccine and is now planning to get permissio…
These are the companies that are making Remdesivir in India
Zydus Cadila has launched Remdesivir under the brand name Remdac, used to treat patients sufferin…
Zydus Cadila’s COVID-19 vaccine for kids above 12 gets approval from India’s drug regulator
With Emergency Use Authorisation (EUA), ZyCoV-D has also become the first vaccine to be administ…
PTI
Pfizer seeks emergency use authorisation for its COVID-19 vaccine in India
"Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use au…
PTI
COVID-19 vaccine by Ahmedabad-based Zydus Cadila gets DCGI nod for human clinical trials
The approval process was fast-tracked following recommendation by the subject expert committee o…
PTI
Cipla to sell anti-viral drug remdesivir as Cipremi in India
In May, US drug maker Gilead Sciences extended a voluntary non-exclusive license to Cipla to man…
Cipla, Zydus Cadila, Jubilant Life and Dr Reddy’s shares gain after FDA approves Remdesivir for treating COVID-19 patients
The shares of pharma major Cipla, Zydus Cadila, Jubilant Life Sciences and Dr Reddy Labs gained dur…
Top stock movers — Tata Motors, SBI Cards, Cochin Shipyard, Zydus Cadila, Cipla, Dr Reddy’s, MphasiS, and others
Indian stock market indices opened on a higher note on Friday, tracking gains in index majors HDFC …
Top stocks to watch — Cipla, Zydus Cadila, Dr Reddy Laboratories, Tech Mahindra, Avenue Supermarts, Cochin Shipyard, and others
Amidst mixed cues from the global markets, the Indian equities are likely to open flat on Friday. T…
These are the seven Indian pharma players racing to develop COVID-19 vaccine
Vaccines normally require years of testing and additional time to produce at scale, but scientis…
Zydus Cadila begins human clinical trials of COVID-19 vaccine candidate
The adaptive phase I/ II human clinical trials of ZyCoV-D have commenced with the first human d…
PTI
Zydus Cadila launches research prog to develop vaccine for coronavirus
The second approach deals with development of a live attenuated recombinant measles virus vectored …
PTI
Zydus Cadila gets USFDA nod to market ointment for treating skin conditions
The company has received final approval from the United States Food and Drug Administration (USFDA…
PTI
COVID-19 vaccine development at early stage in India; breakthrough unlikely within a year, say experts
Referring to a vaccine to fight the virus, a PMO statement had said that it is the most pressi…
PTI
Zydus Cadila gets DCGI nod for Saroglitazar to treat liver disease
Commenting on the approval, Zydus Group Chairman Pankaj Patel said, "We are happy that our efforts …
PTI
Zydus Cadila gets approval from Mexican authority to test COVID-19 drug
"Clinical and regulatory development of Desidustat in COVID-19 is being executed in Mexico by Avan…
PTI
Potential COVID-19 vaccine by Zydus Cadila gets DCGI nod for human clinical trials
"DCGI Dr V G Somani has given approval for the phase I and II clinical trials (on humans) of the po…
PTI
Zydus Cadila gets final nod from USFDA to market generic seizures drug
The company has received final approval from the United States Food and Drug Administration (USFDA…
PTI
Zydus Cadila inks licensing pact with XOMA Corp to develop cancer treatment molecule
"IL-2 will be the backbone of IO-based therapies for cancer treatment in the future. In this win-wi…